Status:
UNKNOWN
Pharmacokinetic Study to Rectal and Sublingual Administration of Tacrolimus in Future Kidney Transplant Patients
Lead Sponsor:
Maastricht University Medical Center
Conditions:
Organ Transplantation
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to investigate the pharmacokinetics of rectal and sublingual administration of tacrolimus and to compare with pharmacokinetics after oral administration of tacrolimus in r...
Eligibility Criteria
Inclusion
- Patients that will have a kidney transplant patient and will be treated with tacrolimus. As well as hemodialysis patients as well as peritoneal dialysis patients are included.
- Age: 18 - 65 years
- Patient's informed consent
Exclusion
- Patients that use drugs that interact with tacrolimus
- Patients that participate in other studies
- Patients that are treated with tacrolimus
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2011
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT00987103
Start Date
September 1 2009
End Date
September 1 2011
Last Update
October 22 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maastricht University Hospital
Maastricht, Netherlands, 6229 HX